Visible Genetics Revenues Drop As Company Shifts Kit Marketing Strategy | GenomeWeb

NEW YORK, March 8 – Visible Genetics revenues for 2000 dropped slightly to $13.1 million, from $13.6 million in 1999, due to a shift in its marketing strategy for its sequencing kits, the company said Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.